| Median time in years from infection to AIDS death for males |
8.6 |
7.4–9.8 |
| Median time in years from infection to AIDS death for females |
9.4 |
8.2–10.6 |
| Cumulative mortality in HIV+ children |
|
|
| 2 years |
0.48 |
0.30–0.55 |
| 5 years |
0.60 |
0.41–0.55 |
| 10 years |
0.82 |
0.62–1.00 |
| 15 years |
1.00 |
0.74–1.00 |
| Ratio of prevalence for 15–19 to 25–29 for males |
0.19 |
0.05–0.31 |
| Ratio of prevalence for 20–24 to 25–29 for males |
0.30 |
0.05–0.62 |
| Ratio of prevalence for 15–19 to 25–29 for females |
0.22 |
0.01–0.36 |
| Ratio of prevalence for 20–24 to 25–29 for females |
0.63 |
0.53–0.72 |
|
Mean |
Standard deviation |
| Mother to child transmission rate with no prophylaxis |
0.35 |
0.05 |
| Mother to child transmission rate with prophylaxis |
0.28 |
0.05 |
| Ratio of fertility of HIV+ to HIV− women aged 15–19 |
1.5 |
0.20 |
| Ratio of fertility of HIV+ to HIV− women aged 20–49 |
0.70 |
0.10 |
| Percent of adults on ART surviving to the next year |
0.90 |
0.05 |
| Percent of children on cotrimoxazole surviving to the next year |
0.91 |
0.05 |
| Percent of children on antiretroviral treatment surviving to the next year |
0.90 |
0.05 |
